Market revenue in 2023 | USD 1,813.3 million |
Market revenue in 2030 | USD 3,943.8 million |
Growth rate | 11.7% (CAGR from 2023 to 2030) |
Largest segment | Bioreactors/fermenters |
Fastest growing segment | Cell Culture Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.
Bioreactors/fermenters was the largest segment with a revenue share of 31.36% in 2023. Horizon Databook has segmented the Germany upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is home to several established bioprocessing industry participants who have ensured easy access to novel upstream bioprocessing equipment for researchers and healthcare professionals in the country. This is expected to significantly contribute to the dominance of Germany in Europe’s upstream bioprocessing market over the forecast period.
Several companies are undertaking business initiatives to strengthen their presence in the upstream bioprocessing market. For instance, in August 2023, Sartorius AG partnered with Repligen Corporation to launch an integrated system with XCell ATF and Biostat STR to intensify the upstream process.
Moreover, in January 2021, Eppendorf SE, a German-based life sciences company, announced the expansion of its integrated upstream bioprocess single-use solutions. In addition, in November 2021, Yokogawa Electric Corporation acquired Insilico Biotechnology AG (“Insilico”), a Germany-based developer & provider of bioprocess services and software.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany upstream bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into Germany upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account